Current stem cell research & therapyHumansNon-alcoholic Fatty Liver DiseaseMesenchymal Stem Cell TransplantationMesenchymal Stem CellsLiver Cirrhosis
Therapeutic Role of Bone Marrow Mesenchymal Stem Cells (BMSCs) in Nonalcoholic Steatohepatitis (NASH) Cirrhosis.
Hai-Tang Jiang, Hao-Ming Ye, Hua-Yang Yu, Yi-Ping Zhu, Ming-Yu Hu, Man-Li He, Wei-Yao Li, Ze-Hui Yu, Qian Yang, Lv-Qin He, Cong-Wei Gu
Published: 202510.2174/011574888X328447241023063825
Abstract
NASH cirrhosis is a late-stage nonalcoholic fatty liver disease (NAFLD) characterized by high morbidity, high relapse rate, and high mortality, which is clinical to treat. Presently, liver transplantation is the most effective radical treatment, but…
Preview only. Read the full abstract at the source